2,3-N-octanoyl-D-erythro-trans-sphingosine,
2,3-N-octanoylsphingosine,
C8-ceramide,
C8 ceramide,
N-octanoylsphingosine,
74713-59-0,
C-8 Ceramide,
CHEBI:45815,
D-erythro-Sphingosine, N-Octanoyl-,
N-[(2S,3R,4E)-1,3-dihydroxyoctadec-4-en-2-yl]octanamide,
C8-ceramide,
N-octanoyl-D-erythro-sphingosine,
N-octanoyl sphingosine,
AC1NWBN3,
N-octanoylsphing-4-enine,
BSPBio_001569,
BML3-D01,
CHEMBL444463,
N-Octanoylsphingosine,D-erythro,
SCHEMBL14020687,
C26H51NO3,
Cer(d18:1/8:0),
APDLCSPGWPLYEQ-WRBRXSDHSA-N,
HMS1361O11,
HMS1791O11,
HMS1989O11,
HMS3402O11,
HMS3649E13,
C8 Ceramide (d18:1/8:0),
EX-A1429,
ZINC8860495,
1650AH,
MFCD00236496,
N-Octanoyl-D-sphingosine, waxy solid,
IDI1_034039,
NCGC00161360-01,
NCGC00161360-02,
NCGC00161360-03,
SR-01000946565,
SR-01000946565-1,
I14-62015,
N-((2S,3R,E)-1,3-dihydroxyoctadec-4-en-2-yl)octanamide,
N-[(E,2S,3R)-1,3-dihydroxyoctadec-4-en-2-yl]octanamide,
C8 Ceramide (d18:1/8:0), N-octanoyl-D-erythro-sphingosine, powder,
2,3-N-octanoylsphingosine,
Bio1_000811,
CID5702614,
2,3-N-octanoyl-D-erythro-trans-sphingosine,
C066099,
N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)heptadec-3-en-1-yl]octanamide,